Kingdon Capital Management, L.L.C. Sage Therapeutics, Inc. Transaction History

Kingdon Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$89.33 - $163.65 $13.1 Million - $23.9 Million	-146,179 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $12 Million - $20.4 Million	146,179 New	146,179 $14 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $4.99 Million - $6.24 Million	-35,518 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $14.5 Million - $18.3 Million	-94,998 Reduced 72.79%	35,518 $5.72 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $7.92 Million - $21.8 Million	130,516	130,516 $21.5 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.